Skip to content
About us
CYCLOPS
News
Products
Collaborations
Vacancies
Contact
Menu
About us
CYCLOPS
News
Products
Collaborations
Vacancies
Contact
Cyclops
Convenient
Reliable
Easy-to-use
Easy-to-carry
Hygienic
Less Cough
About us
CYCLOPS
News
Products
Collaborations
Vacancies
Contact
Menu
About us
CYCLOPS
News
Products
Collaborations
Vacancies
Contact
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
I. Sibum, P. Hagedoorn, H.W. Frijlink, F. Grasmeijer
International Journal of Pharmaceutics,
2019,
11 (5)
(DOI: 10.3390/pharmaceutics11050233)
SHARE THIS POST
Recent Posts
Fysisch-chemisch analist
Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™
Senior technician, future head
Clinical program manager
PureIMS present at DDL2022
PureIMS appoints Jaap Wieling, PhD, as new CEO
Levodopa Cyclops™ in Dutch magazine ‘Tijdschrift voor Neurologie en Neurochirurgie (TNN)’
PureIMS participating in Biotech Showcase™ 2022
Towards a cure for Mycobacterium abscessus disease using inhaled tigecycline
PureIMS to present at Biotech Showcase™ Digital 2021
Categories
Categories
Press release
(9)
Publication
(2)
Scientific publication
(5)
Status update
(3)
Vacancies
(3)